329 related articles for article (PubMed ID: 25714364)
21. Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers.
Chaturvedi AK; Mbulaiteye SM; Engels EA
Ann Epidemiol; 2008 Mar; 18(3):230-4. PubMed ID: 18083545
[TBL] [Abstract][Full Text] [Related]
22. Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohort.
Hleyhel M; Belot A; Bouvier AM; Tattevin P; Pacanowski J; Genet P; De Castro N; Berger JL; Dupont C; Lavolé A; Pradier C; Salmon D; Simon A; Martinez V; Costagliola D; Grabar S;
Clin Infect Dis; 2013 Dec; 57(11):1638-47. PubMed ID: 23899679
[TBL] [Abstract][Full Text] [Related]
23. Virologic and Immunologic Outcomes in HIV-Infected Patients with Cancer.
Riedel DJ; Stafford KA; Vadlamani A; Redfield RR
AIDS Res Hum Retroviruses; 2017 May; 33(5):482-489. PubMed ID: 27824263
[TBL] [Abstract][Full Text] [Related]
24. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study.
Crum-Cianflone N; Hullsiek KH; Marconi V; Weintrob A; Ganesan A; Barthel RV; Fraser S; Agan BK; Wegner S
AIDS; 2009 Jan; 23(1):41-50. PubMed ID: 19050385
[TBL] [Abstract][Full Text] [Related]
25. [Epidemiology of HIV-associated malignancies].
Launay O; Guillevin L
Bull Cancer; 2003 May; 90(5):387-92. PubMed ID: 12850760
[TBL] [Abstract][Full Text] [Related]
26. Reduced incidence of Kaposi's sarcoma and of systemic non-hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy.
Carrieri MP; Pradier C; Piselli P; Piche M; Rosenthal E; Heudier P; Durant J; Serraino D
Int J Cancer; 2003 Jan; 103(1):142-4. PubMed ID: 12455069
[No Abstract] [Full Text] [Related]
27. Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States.
Simard EP; Pfeiffer RM; Engels EA
Cancer; 2011 Mar; 117(5):1089-96. PubMed ID: 20960504
[TBL] [Abstract][Full Text] [Related]
28. Projected Cancer Incidence Rates and Burden of Incident Cancer Cases in HIV-Infected Adults in the United States Through 2030.
Shiels MS; Islam JY; Rosenberg PS; Hall HI; Jacobson E; Engels EA
Ann Intern Med; 2018 Jun; 168(12):866-873. PubMed ID: 29801099
[TBL] [Abstract][Full Text] [Related]
29. AIDS-associated cancers: an emerging challenge.
Phatak UA; Joshi R; Badakh DK; Gosavi VS; Phatak JU; Jagdale RV
J Assoc Physicians India; 2010 Mar; 58():159-62. PubMed ID: 20848813
[TBL] [Abstract][Full Text] [Related]
30. Cancer in people living with HIV-AIDS at a referral hospital in Lima, Peru.
Mendoza-Mori LM; Valenzuela-Medina JB; Gotuzzo E; Mejía-Cordero FA; González-Lagos EV
Rev Peru Med Exp Salud Publica; 2021; 38(2):278-283. PubMed ID: 34468576
[TBL] [Abstract][Full Text] [Related]
31. Non-AIDS-defining cancers among HIV-infected people.
Pinzone MR; Fiorica F; Di Rosa M; Malaguarnera G; Malaguarnera L; Cacopardo B; Zanghì G; Nunnari G
Eur Rev Med Pharmacol Sci; 2012 Oct; 16(10):1377-88. PubMed ID: 23104654
[TBL] [Abstract][Full Text] [Related]
32. Immune deficiency and risk for malignancy among persons with AIDS.
Mbulaiteye SM; Biggar RJ; Goedert JJ; Engels EA
J Acquir Immune Defic Syndr; 2003 Apr; 32(5):527-33. PubMed ID: 12679705
[TBL] [Abstract][Full Text] [Related]
33. Cancer and AIDS.
Chitale AR
Indian J Pathol Microbiol; 2005 Apr; 48(2):151-60. PubMed ID: 16758653
[TBL] [Abstract][Full Text] [Related]
34. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
35. Retrospective cohort study of cancer incidence and mortality by HIV status in a Georgia, USA, prisoner cohort during the HAART era.
Zlotorzynska M; Spaulding AC; Messina LC; Coker D; Ward K; Easley K; Baillargeon J; Mink PJ; Simard EP
BMJ Open; 2016 Apr; 6(4):e009778. PubMed ID: 27067888
[TBL] [Abstract][Full Text] [Related]
36. AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy.
Bower M; Palmieri C; Dhillon T
Curr Opin Infect Dis; 2006 Feb; 19(1):14-9. PubMed ID: 16374212
[TBL] [Abstract][Full Text] [Related]
37. Study of 172 Cases of AIDS Associated Cancers.
Phatak UA; Gosavi VS; Chitale PV
J Assoc Physicians India; 2022 Jan; 70(1):11-12. PubMed ID: 35062808
[TBL] [Abstract][Full Text] [Related]
38. Risk of cancers during interrupted antiretroviral therapy in the SMART study.
Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI
AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103
[TBL] [Abstract][Full Text] [Related]
39. Differences in survival according to malignancy type and degree of immunodeficiency in HIV-infected patients.
Fernández-Ruiz A; Sanjoaquín-Conde I; Letona-Carbajo S; Lambea-Sorrosal JJ; Crusells-Canales MJ
Med Clin (Barc); 2020 Apr; 154(8):295-300. PubMed ID: 31471061
[TBL] [Abstract][Full Text] [Related]
40. Cancer incidence among an HIV-infected cohort. Pulmonary Complications of HIV Infection Study Group.
Johnson CC; Wilcosky T; Kvale P; Rosen M; Stansell J; Glassroth J; Reichman L; Wallace J; Markowitz N; Thompson JE; Hopewell P
Am J Epidemiol; 1997 Sep; 146(6):470-5. PubMed ID: 9290507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
